OCTAGON CAPITAL ADVISORS LP
Adviser information for OCTAGON CAPITAL ADVISORS LP last updated from Form ADV on March 21st, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 9 |
|---|---|
| Investment Advisory/Research | 7 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 6 | $951.8M |
| Non-Discretionary | 0 | $0 |
| Total | 6 | $951.8M |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 6 | $951.8M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 50 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
654 MADISON AVENUE, 21ST FLOORNEW YORK
NY
United States
Monday - Friday, 8:00 AM - 5:00 PM
Tel: 212-369-2829, Fax: None
Chief Compliance Officer
JUSTIN HIRSCH
CHIEF FINANCIAL OFFICER
654 MADISON AVENUE, 21ST FLOOR
NEW YORK
NY
United States
Tel:
212-369-2829
J************@****************M
(Full email address available in API data)
Industry Affiliates
| OCTAGON INVESTMENTS GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| OCTAGON INVESTMENTS MASTER FUND LP | Hedge Fund | $834.2M | $5.0M | 132 |
| OCTAGON PRIVATE OPPORTUNITIES FUND LP | Private Equity Fund | $100.8M | $5.0M | 26 |
| OCTAGON SPECIAL OPPORTUNITIES FUND LP | Private Equity Fund | $16.7M | $5.0M | 6 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| HIRSCH, JUSTIN, M | Individual | – | CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER | 11/2019 | < 5% |
| JIA, TING, (NMN) | Individual | – | FOUNDER, PORTFOLIO MANAGER, AND LIMITED PARTNER | 11/2019 | > 75% |
| OCTAGON CAPITAL ADVISORS, LLC | Domestic Entity | – | GENERAL PARTNER | 11/2019 | < 5% |
| JIA, TING, (NMN) | Individual | OCTAGON CAPITAL ADVISORS, LLC | MANAGING MEMBER | 11/2019 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ADICET BIO INC | COM | 929K | 768K | – |
| AEROVATE THERAPEUTICS INC | COM | 773K | 465K | – |
| AKERO THERAPEUTICS INC | COM | 7M | 283K | – |
| ALLOVIR INC | COM | 7M | 10M | – |
| AN2 THERAPEUTICS INC | COM | 7M | 3M | – |
| ANNEXON INC | COM | 2M | 400K | – |
| APELLIS PHARMACEUTICALS INC | COM | 8M | 200K | – |
| APELLIS PHARMACEUTICALS INC | COM | 6M | 150K | – |
| APELLIS PHARMACEUTICALS INC | COM | 111M | 3M | – |
| ARRIVENT BIOPHARMA INC | COM | 33M | 2M | – |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 612K | 176K | – |
| BRIDGEBIO PHARMA INC | COM | 17M | 690K | – |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 21M | 2M | – |
| CENTURY THERAPEUTICS INC | COM | 3M | 1M | – |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 22M | 488K | – |
| CYBIN INC | COM | 5M | 19M | – |
| DIANTHUS THERAPEUTICS INC | COM | 45M | 2M | – |
| DYNE THERAPEUTICS INC | COM | 42M | 1M | – |
| ELEVATION ONCOLOGY INC | COM | 2M | 747K | – |
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 10M | 1M | – |
| FATE THERAPEUTICS INC | COM | 2M | 521K | – |
| GOSSAMER BIO INC | COM | 8M | 9M | – |
| HELIX ACQUISITION CORP II | CL A ORD SHS | 3M | 250K | – |
| INSMED INC | COM PAR $.01 | 17M | 250K | – |
| INSMED INC | COM PAR $.01 | 44M | 650K | – |
| JASPER THERAPEUTICS INC | COM NEW | 7M | 288K | – |
| MERSANA THERAPEUTICS INC | COM | 2M | 992K | – |
| MIND MEDICINE MINDMED INC | COM NEW | 16M | 2M | – |
| MINERALYS THERAPEUTICS INC | COM | 7M | 600K | – |
| NKARTA INC | COM | 1M | 240K | – |
| NUVATION BIO INC | COM CL A | 1M | 432K | – |
| OCULAR THERAPEUTIX INC | COM | 17M | 2M | – |
| PEPGEN INC | COM | 6M | 376K | – |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 16M | 2M | – |
| POSEIDA THERAPEUTICS INC | COM | 2M | 736K | – |
| PRAXIS PRECISION MEDICINES I | COM NEW | 11M | 260K | – |
| RAPT THERAPEUTICS INC | COM | 891K | 292K | – |
| REGULUS THERAPEUTICS INC | COM | 8M | 4M | – |
| RENEO PHARMACEUTICALS INC | COM | 3M | 2M | – |
| SILENCE THERAPEUTICS PLC | ADS | 3M | 176K | – |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 45M | 1M | – |
| TAYSHA GENE THERAPIES INC | COM SHS | 10M | 5M | – |
| TENAYA THERAPEUTICS INC | COM | 8M | 3M | – |
| TERNS PHARMACEUTICALS INC | COM | 9M | 1M | – |
| VENTYX BIOSCIENCES INC | COM | 6M | 2M | – |
| VERONA PHARMA PLC | SPONSORED ADS | 27M | 2M | – |
| VIRIDIAN THERAPEUTICS INC | COM | 8M | 620K | – |